3 completed. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow Cutaneous Leishmaniasis: new trials by email Literature Review of Cutaneous Leishmaniasis trials Research Report on Cutaneous Leishmaniasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Topical 3% Amphotericin B Cream for the Treatment of Cutaneous Leishmaniasis in Colombia Topical Amphotericin B at 3% - Cutaneous Leishmaniasis | Phase 1 / Phase 2 | Completed | Drugs for Neglected Diseases | 80 | 2014-02-01 | 2016-07-26 |
| Safety Study to Evaluate the Leish-111f + MPL-SE Vaccine in the Prevention of Cutaneous Leishmaniasis in Healthy Subjects Previously Exposed to the Leishmania Parasite Leish-111f + MPL-SE vaccine - Cutaneous Leishmaniasis | Phase 1 | Completed | Access to Advanced Health Institute (AAHI) | 12 | 2005-08-01 | 2006-05-05 |
| Safety and Immunogenicity of a Vaccine for Cutaneous Leishmaniasis Using Recombinant Human Interleukin-12 and Aluminum Hydroxide Gel as Adjuvants Combination of autoclaved leishmania antigen with recombinant human interleukin-12 (rhIL-12) and aluminum hydroxide gel as adjuvants - Cutaneous Leishmaniasis | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 50 | 1999-04-01 | 2008-03-04 |
Leishmaniasis, Cutaneous (3) · Leishmaniasis (1) · Parasitic Diseases (1)
Euglenozoa Infections (3) · Infections (3) · Protozoan Infections (3) · Skin Diseases (3) · Skin Diseases, Infectious (3) · Skin Diseases, Parasitic (3) · Skin and Connective Tissue Diseases (3) · Vector Borne Diseases (3) · Leishmaniasis (2) · Parasitic Diseases (2)
Interleukin-12 (1)
Access to Advanced Health Institute (AAHI) (1) · Drugs for Neglected Diseases (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
Colombia (2) · United States (1)